Home > > > Report Detail

Drugs For Benign Prostatic hypertrophy Global Market Report 2020

Publisher Name :
Date: 09-Dec-2019
No. of pages: 200

Drugs For Benign Prostatic hypertrophy Market Global Report 2020 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the global drugs for benign prostatic hypertrophy market.

Reasons to Purchase

- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.

- Create regional and country strategies on the basis of local data and analysis.

- Identify growth segments for investment.

- Outperform competitors using forecast data and the drivers and trends shaping the market.

- Understand customers based on the latest market research findings.

- Benchmark performance against key competitors.

- Utilize the relationships between key data sets for superior strategizing.

- Suitable for supporting your internal and external presentations with reliable high quality data and analysis

- Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:

Where is the largest and fastest growing market for the drugs for benign prostatic hypertrophy? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Drugs For Benign Prostatic hypertrophy Market Global Report from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market.

- The Market Characteristics section of the report defines and explains the market.

- The Market Size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.

- Market Segmentations break down market into sub markets.

- The Regional and Country section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.

- Competitive Landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.

- The Trends and Strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.

Scope

Markets Covered: 1) By Type: Alpha Blocker, 5-alpha Reductase Inhibitor, Phosphodiesterase-5 Inhibitor, Others 2) By End User: Hospital Pharmacies, Retail Pharmacies, Others

Companies Mentioned: Allergan PLC, Astellas Pharma Inc., Boehringer Ingelheim, Eli Lilly and Company, GlaxoSmithKline PLC

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time Series: Five years historic and forecast.

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Drugs For Benign Prostatic hypertrophy Global Market Report 2020

Table of Contents

1. Executive Summary
2. Drugs for Benign Prostatic Hypertrophy Market Characteristics
3. Drugs for Benign Prostatic Hypertrophy Market Size And Growth
3.1. Global Drugs for Benign Prostatic Hypertrophy Historic Market, 2015 - 2019, $ Billion
3.1.1. Drivers Of The Market
3.1.2. Restraints On The Market
3.2. Global Drugs for Benign Prostatic Hypertrophy Forecast Market, 2019 - 2022F, 2025F, 2030F, $ Billion
3.2.1. Drivers Of The Market
3.2.2. Restraints On the Market
4. Drugs for Benign Prostatic Hypertrophy Market Segmentation
4.1. Global Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Alpha Blocker
5-alpha Reductase Inhibitor
Phosphodiesterase-5 Inhibitor
Others
4.2. Global Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
5. Drugs for Benign Prostatic Hypertrophy Market Regional And Country Analysis
5.1. Global Drugs for Benign Prostatic Hypertrophy Market, Split By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
5.2. Global Drugs for Benign Prostatic Hypertrophy Market, Split By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
6. Asia-Pacific Drugs for Benign Prostatic Hypertrophy Market
6.1. Asia-Pacific Drugs for Benign Prostatic Hypertrophy Market Overview
6.2. Asia-Pacific Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
6.3. Asia-Pacific Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
7. China Drugs for Benign Prostatic Hypertrophy Market
7.1. China Drugs for Benign Prostatic Hypertrophy Market Overview
7.2. China Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion
7.3. China Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion
8. India Drugs for Benign Prostatic Hypertrophy Market
8.1. India Drugs for Benign Prostatic Hypertrophy Market Overview
8.2. India Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
8.3. India Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
9. Japan Drugs for Benign Prostatic Hypertrophy Market
9.1. Japan Drugs for Benign Prostatic Hypertrophy Market Overview
9.2. Japan Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
9.3. Japan Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
10. Australia Drugs for Benign Prostatic Hypertrophy Market
10.1. Australia Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
10.2. Australia Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
11. Indonesia Drugs for Benign Prostatic Hypertrophy Market
11.1. Indonesia Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
11.2. Indonesia Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
12. South Korea Drugs for Benign Prostatic Hypertrophy Market
12.1. South Korea Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
12.2. South Korea Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
13. Western Europe Drugs for Benign Prostatic Hypertrophy Market
13.1. Western Europe Drugs for Benign Prostatic Hypertrophy Market Overview
13.2. Western Europe Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
13.3. Western Europe Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
14. UK Drugs for Benign Prostatic Hypertrophy Market
14.1. UK Drugs for Benign Prostatic Hypertrophy Market Overview
14.2. UK Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
14.3. UK Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
15. Germany Drugs for Benign Prostatic Hypertrophy Market
15.1. Germany Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
15.2. Germany Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
16. France Drugs for Benign Prostatic Hypertrophy Market
16.4. France Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
16.5. France Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
17. Eastern Europe Drugs for Benign Prostatic Hypertrophy Market
17.1. Eastern Europe Drugs for Benign Prostatic Hypertrophy Market Overview
17.2. Eastern Europe Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
17.3. Eastern Europe Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
18. Russia Drugs for Benign Prostatic Hypertrophy Market
18.1. Russia Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
18.2. Russia Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
19. North America Drugs for Benign Prostatic Hypertrophy Market
19.1. North America Drugs for Benign Prostatic Hypertrophy Market Overview
19.2. North America Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
19.3. North America Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
20. USA Drugs for Benign Prostatic Hypertrophy Market
20.1. USA Drugs for Benign Prostatic Hypertrophy Market Overview
20.2. USA Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
20.3. USA Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
21. South America Drugs for Benign Prostatic Hypertrophy Market
21.1. South America Drugs for Benign Prostatic Hypertrophy Market Overview
21.2. South America Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
21.3. South America Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
22. Brazil Drugs for Benign Prostatic Hypertrophy Market
22.1. Brazil Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
22.2. Brazil Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
23. Middle East Drugs for Benign Prostatic Hypertrophy Market
23.1. Middle East Drugs for Benign Prostatic Hypertrophy Market Overview
23.2. Middle East Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
23.3. Middle East Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
24. Africa Drugs for Benign Prostatic Hypertrophy Market
24.1. Africa Drugs for Benign Prostatic Hypertrophy Market Overview
24.2. Africa Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
24.3. Africa Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
25. Drugs for Benign Prostatic Hypertrophy Market Competitive Landscape And Company Profiles
25.1. Drugs for Benign Prostatic Hypertrophy Market Competitive Landscape
25.2. Drugs for Benign Prostatic Hypertrophy Market Company Profiles
25.2.1. Allergan PLC
25.2.1.1. Overview
25.2.1.2. Products and Services
25.2.1.3. Strategy
25.2.1.4. Financial Performance
25.2.2. Astellas Pharma Inc.
25.2.2.1. Overview
25.2.2.2. Products and Services
25.2.2.3. Strategy
25.2.2.4. Financial Performance
25.2.3. Boehringer Ingelheim
25.2.3.1. Overview
25.2.3.2. Products and Services
25.2.3.3. Strategy
25.2.3.4. Financial Performance
25.2.4. Eli Lilly and Company
25.2.4.1. Overview
25.2.4.2. Products and Services
25.2.4.3. Strategy
25.2.4.4. Financial Performance
25.2.5. GlaxoSmithKline PLC
25.2.5.1. Overview
25.2.5.2. Products and Services
25.2.5.3. Strategy
25.2.5.4. Financial Performance
26. Key Mergers And Acquisitions In The Drugs for Benign Prostatic Hypertrophy Market
27. Drugs for Benign Prostatic Hypertrophy Market Trends And Strategies
28. Product Pipeline Analysis
29. Drugs for Benign Prostatic Hypertrophy Market Future Outlook and Potential Analysis
30. Appendix
30.1. Abbreviations
30.2. Currencies
30.3. Research Inquiries
30.4. The Business Research Company
30.5. Copyright And Disclaimer



List of Tables

Table 1: Global Historic Market Growth, 2015-2019, $ Billion
Table 2: Global Forecast Market Growth, 2015-2022F, 2025F, 2030F, $ Billion
Table 3: Global Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 4: Global Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 5: Global Drugs for Benign Prostatic Hypertrophy Market, Split By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 6: Global Drugs for Benign Prostatic Hypertrophy Market, Split By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 7: Asia-Pacific, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 8: Asia-Pacific, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 9: China, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 10: China, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 11: India, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 12: India, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 13: Japan, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 14: Japan, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 15: Australia, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 16: Australia, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 17: Indonesia, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 18: Indonesia, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 19: South Korea, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 20: South Korea, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 21: Western Europe, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 22: Western Europe, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 23: UK, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 24: UK, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 25: Germany, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 26: Germany, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 27: France, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 28: France, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 29: Eastern Europe, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 30: Eastern Europe, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 31: Russia, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 32: Russia, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 33: North America, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 34: North America, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 35: USA, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 36: USA, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 37: South America, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 38: South America, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 39: Brazil, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 40: Brazil, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 41: Middle East, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 42: Middle East, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 43: Africa, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 44: Africa, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 45: Allergan PLC Financial Performance
Table 46: Astellas Pharma Inc. Financial Performance
Table 47: Boehringer Ingelheim Financial Performance
Table 48: Eli Lilly and Company Financial Performance
Table 49: GlaxoSmithKline PLC Financial Performance


List of Figures

Figure 1: Global Historic Market Growth, 2015-2019, $ Billion
Figure 2: Global Forecast Market Growth, 2015-2022F, 2025F, 2030F, $ Billion
Figure 3: Global Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 4: Global Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 5: Global Drugs for Benign Prostatic Hypertrophy Market, Split By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 6: Global Drugs for Benign Prostatic Hypertrophy Market, Split By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 7: Asia-Pacific, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 8: Asia-Pacific, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 9: China, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 10: China, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 11: India, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 12: India, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 13: Japan, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 14: Japan, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 15: Australia, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 16: Australia, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 17: Indonesia, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 18: Indonesia, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 19: South Korea, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 20: South Korea, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 21: Western Europe, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 22: Western Europe, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 23: UK, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 24: UK, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 25: Germany, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 26: Germany, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 27: France, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 28: France, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 29: Eastern Europe, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 30: Eastern Europe, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 31: Russia, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 32: Russia, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 33: North America, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 34: North America, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 35: USA, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 36: USA, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 37: South America, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 38: South America, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 39: Brazil, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 40: Brazil, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 41: Middle East, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 42: Middle East, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 43: Africa, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 44: Africa, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 45: Allergan PLC Financial Performance
Figure 46: Astellas Pharma Inc. Financial Performance
Figure 47: Boehringer Ingelheim Financial Performance
Figure 48: Eli Lilly and Company Financial Performance
Figure 49: GlaxoSmithKline PLC Financial Performance
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs